These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3995514)

  • 1. Phase II study of spirogermanium in patients with advanced carcinoma of the cervix.
    Brenner DE; Rosenshein NB; Dillon M; Jones HW; Forastiere A; Tipping S; Burnett LS; Greco FA; Wiernik PH
    Cancer Treat Rep; 1985 Apr; 69(4):457-8. PubMed ID: 3995514
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of spirogermanium in advanced epithelial carcinoma of the ovary.
    Weiselberg L; Budman DR; Schulman P; Vinciguerra V; Degnan TJ; Pasmantier M
    Cancer Treat Rep; 1982 Aug; 66(8):1675-6. PubMed ID: 7201885
    [No Abstract]   [Full Text] [Related]  

  • 3. Continuous-infusion spirogermanium for the treatment of refractory carcinoma of the ovary: a phase II trial.
    Kavanagh JJ; Saul PB; Copeland LJ; Gershenson DM; Krakoff IH
    Cancer Treat Rep; 1985 Jan; 69(1):139-40. PubMed ID: 3967257
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II study of spirogermanium in the treatment of metastatic breast cancer.
    Pinnamaneni K; Yap HY; Legha SS; Blumenschein GR; Bodey GP
    Cancer Treat Rep; 1984 Sep; 68(9):1197-8. PubMed ID: 6478457
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancer.
    Dhingra HM; Umsawasdi T; Chiuten DF; Murphy WK; Holoye PY; Spitzer G; Valdivieso M
    Cancer Treat Rep; 1986 May; 70(5):673-4. PubMed ID: 3708617
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trial of spirogermanium for treatment of advanced breast cancer.
    Falkson G; Falkson HC
    Cancer Treat Rep; 1983 Feb; 67(2):189-90. PubMed ID: 6825129
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy for advanced renal cell cancer with spirogermanium: a Southwest Oncology Group Study.
    Saiers JH; Slavik M; Stephens RL; Crawford ED
    Cancer Treat Rep; 1987 Feb; 71(2):207-8. PubMed ID: 3802117
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial of spirogermanium in breast adenocarcinoma: a Cancer and Leukemia Group B Study.
    Budman DR; Ginsberg S; Perry M; Weinberg V; Schein P; Hanson J; Coleman M; Wood W
    Cancer Treat Rep; 1982 Aug; 66(8):1667-8. PubMed ID: 7105058
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II Eastern Cooperative Oncology Group Study of spirogermanium in previously treated lymphoma.
    Boros L; Tsiatis AA; Neiman RS; Mann RB; Glick JH
    Cancer Treat Rep; 1986 Jul; 70(7):917-8. PubMed ID: 3719586
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metastatic cancer of the prostate: phase II study of spirogermanium (NSC 192965)].
    Bui NB; Chauvergne J; Brunet R; Richaud P; Hoerni B; Lagarde C; Le Guillou M
    Bull Cancer; 1986; 73(1):65-7. PubMed ID: 3779124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II evaluation of spirogermanium in advanced ovarian carcinoma.
    Brenner DE; Jones HW; Rosenshein NB; Forastiere A; Dillon M; Grumbine F; Tipping S; Burnett L; Greco FA; Wiernik PH
    Cancer Treat Rep; 1983 Feb; 67(2):193-4. PubMed ID: 6825131
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study.
    Schulman P; Davis RB; Rafla S; Green M; Henderson E
    Cancer Treat Rep; 1984 Oct; 68(10):1305-6. PubMed ID: 6525606
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II study of spirogermanium in advanced breast cancer.
    Kuebler JP; Tormey DC; Harper GR; Chang YC; Khandekar JD; Falkson G
    Cancer Treat Rep; 1984 Dec; 68(12):1515-6. PubMed ID: 6509457
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II trial of spirogermanium in central nervous system tumors: a Southwest Oncology Group Study.
    Goodwin JW; Crowley J; Tranum B; Vance R; Slavik M; Balcerzak S; Hacker D
    Cancer Treat Rep; 1987 Jan; 71(1):99-100. PubMed ID: 3791276
    [No Abstract]   [Full Text] [Related]  

  • 15. A phase II study of spirogermanium in advanced human malignancy.
    Vogelzang NJ; Gesme DH; Kennedy BJ
    Am J Clin Oncol; 1985 Aug; 8(4):341-4. PubMed ID: 3909806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of spirogermanium in advanced ovarian malignancy.
    Tropé C; Mattsson W; Gynning I; Johnsson JE; Sigurdsson K; Orbert B
    Cancer Treat Rep; 1981; 65(1-2):119-20. PubMed ID: 6261944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of spirogermanium in metastatic prostate cancer.
    Dexeus FH; Logothetis C; Samuels ML; Hossan B
    Cancer Treat Rep; 1986 Sep; 70(9):1129-30. PubMed ID: 3742495
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I trial of spirogermanium given by infusion in a multiple-dose schedule.
    Budman DR; Schulman P; Vinciguerra V; Degnan TJ
    Cancer Treat Rep; 1982 Jan; 66(1):173-5. PubMed ID: 7053254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of spirogermanium as second line therapy in patients with poor prognosis lymphoma. An NCI Canada Clinical Trials Group Study.
    Eisenhauer E; Quirt I; Connors JM; Maroun J; Skillings J
    Invest New Drugs; 1985; 3(3):307-10. PubMed ID: 4066225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary toxicity associated with spirogermanium.
    Dixon C; Hagemeister F; Legha S; Bodey G
    Cancer Treat Rep; 1984 Jun; 68(6):907-8. PubMed ID: 6733705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.